| 1. |
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380: 2095-2128.
|
| 2. |
Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ, 2022, 378: e069679.
|
| 3. |
Soriano JB, Kendrick PJ, Paulson KR, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med, 2020, 8: 585-596.
|
| 4. |
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392: 1736-1788.
|
| 5. |
Chronic obstructive pulmonary disease (COPD) [EB/OL]. WHO, 2025. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
|
| 6. |
Health data overview for the People’s Republic of China [EB/OL]. WHO, 2025. https://data.who.int/countries/156.
|
| 7. |
Palliative care [EB/OL]. WHO, 2025. https://www.who.int/news-room/fact-sheets/detail/palliative-care.
|
| 8. |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 2018, 391: 1706-1717.
|
| 9. |
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of COPD: 2025 Report [EB/OL]. 2025. https://goldcopd.org/.
|
| 10. |
Wagner V, Marks A. What is hospice? JAMA, 2024, 332: 1218.
|
| 11. |
Quinn KL, Shurrab M, Gitau K, et al. Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: a systematic review and meta-analysis. JAMA, 2020, 324: 1439-1450.
|
| 12. |
Baltaji S, Cheronis N, Bajwa O, et al. The role of palliative care in COPD. Crit Care Nurs Q, 2021, 44: 113-120.
|
| 13. |
Mir WAY, Siddiqui AH, Paul V, et al. Palliative care and chronic obstructive pulmonary disease (COPD) readmissions: a narrative review. Cureus, 2021, 13: e16987.
|
| 14. |
Braço Forte C, Sousa S. End of life in COPD patients: time for a change. Breathe (Sheff), 2017, 13: e84-e86.
|
| 15. |
Hospice Friendly Hospitals: Draft Quality Standards for End-of-Life Care in Hospice [S]. Irish Hospice Foundation, Dublin, 2009.
|
| 16. |
Tatum PE, Mills SS. Hospice and palliative care: an overview. Med Clin North Am, 2020, 104: 359-373.
|
| 17. |
路桂军, 姜姗, 李忠, 等. 安宁疗护服务对象准入标准的国际经验与中国实践. 医学与哲学, 2021, 42: 28-31.
|
| 18. |
周玲君, 崔静, Bee Wee, 等. 我国临终关怀准入标准界定的质性研究. 中华现代护理杂志, 2010, 16: 1245-1248.
|
| 19. |
Chinese Expert Consensus Working Group on the Definition of Palliative Care. Chinese expert consensus on the definitions of palliative care and hospice care (2025). Chin Med Sci J, 2025, 40: 89-99.
|
| 20. |
吴琼, 郭秀君, 李状双, 等. 慢性阻塞性肺疾病急性加重期中医临床护理路径的构建. 护理研究, 2019, 33: 3107-3112.
|
| 21. |
郝洁, 乔丽娟, 黄惠涛, 等. 基于德尔菲法和层次分析法构建医院药师工作满意度量表. 中国医院药学杂志, 2021, 41: 200-206.
|
| 22. |
陈皓然, 吴秋惠, 彭宇竹, 等. 慢性阻塞性肺疾病药物治疗管理培训体系的构建. 药学服务与研究, 2021, 21: 332-337.
|
| 23. |
刘爽, 姜丹, 赵荣生. 基于德尔菲法确定霉酚酸治疗药物监测指南的临床问题与结局指标. 中国医院药学杂志, 2022, 42: 1479-1482.
|
| 24. |
张若彬, 吴秋惠, 曹馨瑞, 等. 基于德尔菲法构建药师视角下慢性阻塞性肺疾病患者分级管理标准. 药师与药学服务, 2024, 35: 860-865.
|
| 25. |
王芳, 蔡英华, 许正红, 等. 慢性阻塞性肺疾病个案管理师准入标准体系的构建. 护理研究, 2021, 35: 411-416.
|
| 26. |
孙文, 李珍, 陈佳林, 等. 基于德尔菲法的突发重大传染病社区韧性评价指标体系. 公共卫生与预防医学, 2025, 36: 6-11.
|
| 27. |
文富强, 陈磊. 中国慢性阻塞性肺疾病诊疗的现存问题与思考. 中华医学杂志, 2020, 100: 81-84.
|
| 28. |
蹇在金. 现代老年医学理念 1234. 中华老年医学杂志, 2016, 35: 805-807.
|
| 29. |
Le Rouzic O, Roche N, Cortot AB, et al. Defining the "frequent exacerbator" phenotype in COPD: a hypothesis-free approach. Chest, 2018, 153: 1106-1115.
|
| 30. |
Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998, 157: 1418-1422.
|
| 31. |
Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2017, 195: 324-330.
|
| 32. |
Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest, 2003, 124: 459-467.
|
| 33. |
李书娇, 郭园润, 王明哲, 等. 664 例慢性阻塞性肺疾病急性加重老年患者 3 年生存状况及中西医预后影响因素. 北京中医药大学学报, 2024, 47: 1288-1296.
|
| 34. |
Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration, 2012, 84: 17-26.
|
| 35. |
林泽辉, 许银姬. 慢性阻塞性肺疾病急性加重患者住院死亡结局预测模型研究. 临床肺科杂志, 2020, 25: 1175-1179.
|
| 36. |
吴哲, 董万里, 李克芳, 等. AECOPD 并呼吸衰竭患者预后相关因素分析及预测模型构建. 医药论坛杂志, 2025, 46: 253-259.
|
| 37. |
Peng L, Yi Q, Luo Y, et al. Derivation and validation of a new score for predicting in-hospital mortality in exacerbations of chronic obstructive pulmonary disease. J Gen Intern Med, 2025, 40(13): 3068-3077.
|